Review
Jul 2026
Personalized antiplatelet therapy: are we ready for a precision medicine approach
Evidence suggests that genotype-guided therapy, PFT-guided treatment, and individualized DAPT duration may improve the balance between ischemic protection and bleeding risk in selected high-risk populations, but routine implementation remains limited by inconsistent clinical outcome benefits.
Sai Praneeth Chaparala, Abhishek Hanumanpratap Singh Kshatri, Amritha Suresh et al.
· Journal of Basic and Clinica... · 0 citations